{"ticker": {"uuid": "d75b4106-c7a2-4ecb-868f-eae659219553", "symbol": "1530", "name": "3SBio Inc.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "3SBio stock stays centered on its Hong Kong listing. Business context remains the core story.", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQSWU5MHdmd0JsVDFhcjdoUXctTkdsSnF1LVQ3OHVMNEdKdGh0V1RNQWk2NEdXbmtQLUZ5a2owTXZjRUQ3M0xyY0pvZ1Yza0dBMlJhTTRjYWsyek9VQ1FVMkVQUkhxOEM1Tm9vcGRrQWljZkdfS2tCN1RCR09HVjc0Z09iRXU1bmk1TS02cGhZUUhhdDZ1cHROQnltV1U0dmF2bE5aQUVvOW9xc3JyVVpBREFnU3ljZURTOGp3N1NFMHk2XzR0MkE?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T15:45:46+00:00", "published_display": "08 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio (SEHK:1530) Declares Final Dividend, Is The Stock Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQbDNFZFRDOFVtTGREbFNIRHNNNEZjMlFaVWJib19YdEZhVXkzWG9BSTRvQndHcjJXaGR4N3Y4WnAwckd2bzU2NFdqN20yWnFMN3cwSEt5eTNMdTJPU1dVakR6dWFya3hYd0ZsVTNCNExLSUxRN1pVbXRRX3M4VzF1MTlyNml4cE1EWU5ydkU5UE02QWdoWXRHLTBzSzIwbTlQczRqT1ZnbmJQcUVNQ3lJaFNJTlp4dGVBSFk5aHpyRS13a3RoVUVTa28xLXpNMDYyM3JJQWh3VDdwcm_SAeABQVVfeXFMTjZ1ZG9IVTU5QzFZd1hrVkFET2FzSk9WdXgtMzNQT3pLSVc3b2hVWndNTi1lak02SURRZTdZQWt5TmhHTkF5WEo2VW1ub2kyZmZGdnBwdW9GT3FQbnhaNXBBTkpvRGljZ0xaeUVxUEdWVU9NMHg0X09ZRmRnMjQwaFN0bXNSalhJZm5LMkNXOFM4ejZZakVVZ0twbGlrZ0RxZml2dlItdENEU3lJY0FaUzhQTGQ5WUpoUk5uR1V3RU5jdmRLbE13aFdTczFINlFHaDZPOXFkTGctRTRPVGtDYUU?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T12:59:09+00:00", "published_display": "06 Jul 2026 12:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio highlights its biotech profile as investors look at long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQRTRLbWM4TzNOOUNCQ1JIMk1HT0Z2aEllV09MM0k2LXV3ejB1V1RrNUVxMTFyRVd6QVBrM2RDa3FxaXpiSHkzUmV4TUk0WnY2TEo4Rk02eGh4b283YjR2Y0dBcm92RlV5X3UtVEx3SFprZEIyZ0huWEdqUHVrVmstc0lfbzRkSlVTeWVkUVN2RXp6NENRTVd6NDlkam9yNzFQSUYyMWFHRVUwOGRGVlpjZ0JHNHBpbllCaUR4cHY3RHktSW81UUk3VlFLT2VFQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T14:07:00+00:00", "published_display": "04 Jul 2026 14:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio (SEHK:1530) Valuation Check After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQQUpmdDk1SGNrSkRzS2F4MU9seWlsZW9PRV9wMS1vWmVROFZDS2lGYVdheGtVM0cwMml4blU2bGhpUldIRDQtYlBpUWJKMk96VlBhWVY1WmhZcmN1UkJVUG40NmtZemt0bHpnbjFjcWNTN3VQbWZjT21hd0hObXpMUzJFVQ?oc=5", "source_name": "Market source", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why 3SBio (SEHK:1530) Is Down 10.1% After HK$3.12 Billion Follow-on Equity Offering And Portfolio Shift", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer bets $6B+ on 3Sbio\u2019s bispecific PD-1/VEGF antibody", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTkd4M1hlSHFSc3FaTk40MzhjTWZqaS1YZnFxNmRsdHRiVndUM2tVN0w3OGVpZ3daaHBBLV9RMnJGdll5OXBBNXB6WUxHbWp4eTJiUERJTHJhZTlBWUJlUjI4Qk5wTm5mam1uX0JYOUxVX2Q0UU5Jek9vNE9wTDNFcGN6TWRlSkt4d21scUI1RUd2WkNuR3JEUmp5TQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-05-20T07:00:00+00:00", "published_display": "20 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQZFVrRFpUMUtKeHpVbUwwUUsxTmZGeHRMZEdiU2R1UTZCOXBPY2FkWUdDd1I2VldsRnRkRzY3VC03ZUZycjR3NEJ1R1Z4ZHA4YmFfUGdxUloycG81dzAzZDdIdDZDcmVCUXM5LWVJcjFVU2lvXzNmUmhVdWZVaVdVbU9rbUxVcmhENDAyZlBRRnhFN0RTdnZIcFRwM3gxT0huOFhrdXM3dEt6QWYxTUN3YmMwN3QyT0ljM1l2QjQ3M29OWXBza2x5SkRIZFJLNldtejdSZnA1eUFIUQ?oc=5", "source_name": "Reuters", "published_at": "2025-05-19T07:00:00+00:00", "published_display": "19 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio draws GIC, BlackRock to up to US$712 million Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPeklTenExSllRZ0RqTXVKY0hHVy1oSDZodDhmMlc5LVJ0SUJ1bFpLYzZfQkRtNkNhVXRqV0FGUzZ1ZGQ1cVhBMUllemtTaE83UnJFcHNnZUJfUXZSWTNyMG5TWEpZZC1SaXItS0s0UkhzY19obTZSNkhyLWNzejJrb3JJZ2VpUU1XdzFkc2FoN3NiVmM?oc=5", "source_name": "The Edge Malaysia", "published_at": "2023-05-19T19:33:45+00:00", "published_display": "19 May 2023 19:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of 3SBio, Inc. (HKEX:1530)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTFA3MzdsWFFFUGNtaFQxQkZadXVKNHEtTlBQMi1sZGUzLVc4MFliT01pVElqNlNCTWU2TmwtMnExaHh6MzhOUGtBcS02SHRuRENNTEJtYTRxQlJ2ZXk1dV9RT0NEMk5GUmZQ?oc=5", "source_name": "TradingView", "published_at": "2018-02-03T00:43:14+00:00", "published_display": "03 Feb 2018 00:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "3SBio stock stays centered on its Hong Kong listing. Business context remains the core story.", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQSWU5MHdmd0JsVDFhcjdoUXctTkdsSnF1LVQ3OHVMNEdKdGh0V1RNQWk2NEdXbmtQLUZ5a2owTXZjRUQ3M0xyY0pvZ1Yza0dBMlJhTTRjYWsyek9VQ1FVMkVQUkhxOEM1Tm9vcGRrQWljZkdfS2tCN1RCR09HVjc0Z09iRXU1bmk1TS02cGhZUUhhdDZ1cHROQnltV1U0dmF2bE5aQUVvOW9xc3JyVVpBREFnU3ljZURTOGp3N1NFMHk2XzR0MkE?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T15:45:46+00:00", "published_display": "08 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio (SEHK:1530) Declares Final Dividend, Is The Stock Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQbDNFZFRDOFVtTGREbFNIRHNNNEZjMlFaVWJib19YdEZhVXkzWG9BSTRvQndHcjJXaGR4N3Y4WnAwckd2bzU2NFdqN20yWnFMN3cwSEt5eTNMdTJPU1dVakR6dWFya3hYd0ZsVTNCNExLSUxRN1pVbXRRX3M4VzF1MTlyNml4cE1EWU5ydkU5UE02QWdoWXRHLTBzSzIwbTlQczRqT1ZnbmJQcUVNQ3lJaFNJTlp4dGVBSFk5aHpyRS13a3RoVUVTa28xLXpNMDYyM3JJQWh3VDdwcm_SAeABQVVfeXFMTjZ1ZG9IVTU5QzFZd1hrVkFET2FzSk9WdXgtMzNQT3pLSVc3b2hVWndNTi1lak02SURRZTdZQWt5TmhHTkF5WEo2VW1ub2kyZmZGdnBwdW9GT3FQbnhaNXBBTkpvRGljZ0xaeUVxUEdWVU9NMHg0X09ZRmRnMjQwaFN0bXNSalhJZm5LMkNXOFM4ejZZakVVZ0twbGlrZ0RxZml2dlItdENEU3lJY0FaUzhQTGQ5WUpoUk5uR1V3RU5jdmRLbE13aFdTczFINlFHaDZPOXFkTGctRTRPVGtDYUU?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T12:59:09+00:00", "published_display": "06 Jul 2026 12:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio highlights its biotech profile as investors look at long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQRTRLbWM4TzNOOUNCQ1JIMk1HT0Z2aEllV09MM0k2LXV3ejB1V1RrNUVxMTFyRVd6QVBrM2RDa3FxaXpiSHkzUmV4TUk0WnY2TEo4Rk02eGh4b283YjR2Y0dBcm92RlV5X3UtVEx3SFprZEIyZ0huWEdqUHVrVmstc0lfbzRkSlVTeWVkUVN2RXp6NENRTVd6NDlkam9yNzFQSUYyMWFHRVUwOGRGVlpjZ0JHNHBpbllCaUR4cHY3RHktSW81UUk3VlFLT2VFQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T14:07:00+00:00", "published_display": "04 Jul 2026 14:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio (SEHK:1530) Valuation Check After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQQUpmdDk1SGNrSkRzS2F4MU9seWlsZW9PRV9wMS1vWmVROFZDS2lGYVdheGtVM0cwMml4blU2bGhpUldIRDQtYlBpUWJKMk96VlBhWVY1WmhZcmN1UkJVUG40NmtZemt0bHpnbjFjcWNTN3VQbWZjT21hd0hObXpMUzJFVQ?oc=5", "source_name": "Market source", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why 3SBio (SEHK:1530) Is Down 10.1% After HK$3.12 Billion Follow-on Equity Offering And Portfolio Shift", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer bets $6B+ on 3Sbio\u2019s bispecific PD-1/VEGF antibody", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTkd4M1hlSHFSc3FaTk40MzhjTWZqaS1YZnFxNmRsdHRiVndUM2tVN0w3OGVpZ3daaHBBLV9RMnJGdll5OXBBNXB6WUxHbWp4eTJiUERJTHJhZTlBWUJlUjI4Qk5wTm5mam1uX0JYOUxVX2Q0UU5Jek9vNE9wTDNFcGN6TWRlSkt4d21scUI1RUd2WkNuR3JEUmp5TQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-05-20T07:00:00+00:00", "published_display": "20 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQZFVrRFpUMUtKeHpVbUwwUUsxTmZGeHRMZEdiU2R1UTZCOXBPY2FkWUdDd1I2VldsRnRkRzY3VC03ZUZycjR3NEJ1R1Z4ZHA4YmFfUGdxUloycG81dzAzZDdIdDZDcmVCUXM5LWVJcjFVU2lvXzNmUmhVdWZVaVdVbU9rbUxVcmhENDAyZlBRRnhFN0RTdnZIcFRwM3gxT0huOFhrdXM3dEt6QWYxTUN3YmMwN3QyT0ljM1l2QjQ3M29OWXBza2x5SkRIZFJLNldtejdSZnA1eUFIUQ?oc=5", "source_name": "Reuters", "published_at": "2025-05-19T07:00:00+00:00", "published_display": "19 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3SBio draws GIC, BlackRock to up to US$712 million Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPeklTenExSllRZ0RqTXVKY0hHVy1oSDZodDhmMlc5LVJ0SUJ1bFpLYzZfQkRtNkNhVXRqV0FGUzZ1ZGQ1cVhBMUllemtTaE83UnJFcHNnZUJfUXZSWTNyMG5TWEpZZC1SaXItS0s0UkhzY19obTZSNkhyLWNzejJrb3JJZ2VpUU1XdzFkc2FoN3NiVmM?oc=5", "source_name": "The Edge Malaysia", "published_at": "2023-05-19T19:33:45+00:00", "published_display": "19 May 2023 19:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of 3SBio, Inc. (HKEX:1530)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTFA3MzdsWFFFUGNtaFQxQkZadXVKNHEtTlBQMi1sZGUzLVc4MFliT01pVElqNlNCTWU2TmwtMnExaHh6MzhOUGtBcS02SHRuRENNTEJtYTRxQlJ2ZXk1dV9RT0NEMk5GUmZQ?oc=5", "source_name": "TradingView", "published_at": "2018-02-03T00:43:14+00:00", "published_display": "03 Feb 2018 00:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 78, "total_relevant": 9, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 8, "score": 52, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 3.85, "count": 7}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 18.07, "latest_week": "2026-07-10", "one_week_move": -7.6, "four_week_move": 9.1, "twelve_week_move": -28.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.883234, "market_dynamics_buy_signal": false, "relative_strength": -24.789155, "fair_value_gap": 30.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 43.3824, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.6% over one week, +9.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ad-hoc-news.de", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Market source", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "The Edge Malaysia", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-7.6% over one week, +9.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "3SBio stock stays centered on its Hong Kong listing. Business context remains the core story."}], "updated_at": "2026-07-18T03:49:28.088138+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}